Principal Investigator
Marijo Bilusic
Enrollment Status
Closed
Clinical Trial ID
Institutional Protocol #
20230629
Clinical Trial Summary
A Phase 1/2 Study of Replicating Arenavirus-based Vector(s) Encoding Prostate Cancer-Associated Antigens in Participants With Metastatic Castration-Resistant Prostate Cancer
Phase
Phase I/II
Funding Agency/Sponsor
Industrial
Disease
Prostate, Bladder, and Kidney Cancers
Contact Information
Phone Number
305-243-2647